Test 2 Treat: Improving Cholesterol Management After a Heart Event
This study, called "Test 2 Treat," is looking at ways to improve how high cholesterol (LDL-C) is tested and treated in patients who have been hospitalized for a heart event like a heart attack (STEMI or NSTEMI) or a procedure to open blocked heart arteries (percutaneous coronary revascularization). Researchers want to see if educating doctors and patients, and having a "care champion" communicate with patients after they leave the hospital, can help more people reach their cholesterol goals. The care champion will encourage patients to stick to their cholesterol-lowering medication, get their cholesterol retested, and follow up with their doctor. The main goal is to see if these efforts lead to a better reduction in LDL-C levels within 6 to 8 months after leaving the hospital. You may be eligible if you are 18 or older, had a recent heart event, and have an LDL-C level of 70 mg/dL or higher during your hospital stay.
- Study design
- This interventional study plans to enroll 400 participants. It compares patients who receive support from a "care champion" to those who do not, to see if the care champion helps lower cholesterol.
- What's involved
- You will provide clinical data and patient-reported outcomes at baseline and 6 months. Your care champion will also record data related to their communication with you.
- Compensation
- Not stated in the trial record.
- Follow-up
- Your LDL-C levels will be tracked from your hospital admission up to 6 to 8 months after you are discharged.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Test 2 Treat: Can we Improve the Testing and Treatment of High Cholesterol in Patients Who Have Been Hospitalized for a Cardiac Event by Providing Education to Doctors and Patients?
At a glance
Conditions
Where it's being run
1 sites across 1 statesWho to contact
Opens a ready-to-send draft in your own email app — review before sending.
What this trial measures
- Within-patient change in LDL-C (low-density lipoprotein cholesterol) from baseline (during admission) to last LDL-C level checked within 6+2 (8) months post-dischargeBaseline to 6+2 (8) months post-discharge
To test effectiveness of implementing a care champion intervention to help patients navigate the inpatient-to-outpatient transition after hospitalization for MI and/or percutaneous coronary revasc., in order to improve the achievement of LDL-C goals.